as an add-on maintenance treatment for adult patients with inadequately controlled chronic obstructive pulmonary disease (COPD). Nucala stands out as the only approved biologic that has been ...

The conditions of participants ranged from moderate to severe, or stages 2–4 as assessed by the medically recognized scale of the Global Initiative for Chronic Obstructive Lung Disease (GOLD). During ...

May 22 (Reuters) - The U.S. Food and Drug Administration has approved British drugmaker GSK's (GSK.L), opens new tab asthma drug to treat some patients with a chronic lung disease commonly known ...

SAN FRANCISCO – The recent outbreak of lung injuries linked to vaping has highlighted the dangers of e-cigarettes. A new study puts the warning in big, red letters. Often promoted as a ...

But a bout of pneumonia and subsequent viral infection triggered a rare lung disease that has inflamed and scarred her airways. Her fall and winter were filled with hospital admissions and visits ...

Despite hiring a commercial chief and sponsoring disease awareness efforts last year, Savara will have to wait a while longer for a potential approval of its inhaled lung disease asset molgramostim.

IT’S NOT GOING TO HELP BURN BELLY FAT, BUT IT IS HELPING SOME PEOPLE WITH A PROGRESSIVE LUNG DISEASE BREATHE ... by the COPD (Chronic Obstructive Pulmonary Disease) Foundation.

evaluating the investigational use of itepekimab in adults who were former smokers with inadequately controlled chronic obstructive pulmonary disease (COPD) met the primary endpoint of ...

and pulmonary hypertension associated with interstitial lung disease (PH-ILD) to improve exercise ability. YUTREPIA is the first and only prostacyclin dry-powder formulation enabled by Liquidia ...